- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medicenna Therapeutics Corp (MDNA)
Medicenna Therapeutics Corp stock price live, this page displays TSX MDNA stock exchange data. View the MDNA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Medicenna Therapeutics Corp real time stock price chart below.
What Is the Medicenna Therapeutics Corp Stock Price Today?
The Medicenna Therapeutics Corp stock price today is 1.12.
What Is the Stock Symbol for Medicenna Therapeutics Corp?
The stock symbol for Medicenna Therapeutics Corp is ""MDNA.""
What Stock Exchange Does Medicenna Therapeutics Corp Trade On?
Medicenna Therapeutics Corp is listed and trades on the Toronto stock exchange.
Is Medicenna Therapeutics Corp a Good Stock to Buy?
Determining whether Medicenna Therapeutics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MDNA quote. (ISIN: CA58490H1073)
What Is the Medicenna Therapeutics Corp Stock Price Today?
The Medicenna Therapeutics Corp stock price today is 1.12.
What Is the Stock Symbol for Medicenna Therapeutics Corp?
The stock symbol for Medicenna Therapeutics Corp is ""MDNA.""
What Stock Exchange Does Medicenna Therapeutics Corp Trade On?
Medicenna Therapeutics Corp is listed and trades on the Toronto stock exchange.
Is Medicenna Therapeutics Corp a Good Stock to Buy?
Determining whether Medicenna Therapeutics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MDNA quote. (ISIN: CA58490H1073)
1.12
-0.02(-1.75%)
Closed·
Fair Value
An estimate of a Medicenna's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.12
1.15
52 wk Range
0.78
2.63
MDNA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MDNA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Medicenna's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.121.15
52 wk Range
0.782.63
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MDNA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Medicenna's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
3.75
Upside
+234.82%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Medicenna Therapeutics Corp Company Profile
Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, a long-acting interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a tumor-targeting and activatable masked anti-PD-1-IL-2 BiSKITTM for cancer; and MDNA132, an IL-13 Superkine for various tumors. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.
Compare MDNA to Peers and Sector
Metrics to compare | MDNA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMDNAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.3x | −8.8x | −0.6x | |
PEG Ratio | −0.13 | −0.02 | 0.00 | |
Price/Book | 6.6x | −1.2x | 2.6x | |
Price / LTM Sales | - | 154.6x | 3.3x | |
Upside (Analyst Target) | 234.8% | 204.3% | 39.0% | |
Fair Value Upside | Unlock | −9.4% | 4.9% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 3.75
(+234.82% Upside)
Earnings
Latest Release
Jul 31, 2025
EPS / Forecast
-0.06 / -0.06
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Medicenna Trade On?
Medicenna is listed and trades on the Toronto Stock Exchange stock exchange.
What Is the Stock Symbol for Medicenna?
The stock symbol for Medicenna is "MDNA."
What Is the Medicenna Market Cap?
As of today, Medicenna market cap is 95.19M.
What Is Medicenna's Earnings Per Share (TTM)?
The Medicenna EPS (TTM) is -0.17.
When Is the Next Medicenna Earnings Date?
Medicenna will release its next earnings report on 13 Nov 2025.
From a Technical Analysis Perspective, Is MDNA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Medicenna Stock Split?
Medicenna has split 1 times.
How Many Employees Does Medicenna Have?
Medicenna has 18 employees.
What is the current trading status of Medicenna (MDNA)?
As of 26 Aug 2025, Medicenna (MDNA) is trading at a price of 1.12, with a previous close of 1.14. The stock has fluctuated within a day range of 1.12 to 1.15, while its 52-week range spans from 0.78 to 2.63.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.